Semler Scientific (SMLR)


Financial Snapshot (Last 12 Months):

Market Cap: $39.10M Revenues: $1.90M Net Income: $-2.36M

Deal Structure

Filing Date:Nov. 15, 2013 Expected to Trade:Feb. 21, 2014 Status:Priced Lead Underwriters:Aegis Capital Co-Managers:-
Shares Offered:1.18M Deal Type:IPO Price Range:$7.50 - $9.50 Issue Price:$7.00

Company

Business Profile

We are an emerging medical risk-assessment company. Our mission is to develop, manufacture and market patented products that identify the risk profile of medical patients to allow healthcare providers to capture full reimbursement potential for their services. Our first patented and U.S. Food and Drug Administration, or FDA, cleared product, is FloChec™. FloChec™ is used in the office setting to allow providers to measure arterial blood flow in the extremities and is a useful tool for internists and primary care physicians for whom it was previously impractical to conduct blood flow measurements. FloChec™ received FDA 510(k) clearance in February 2010, we began Beta testing in the third quarter of 2010, and we began commercially leasing FloChec™ in January 2011.

Industry: Health Care Founded: 2007 Employees: 11 Prospectus: Click Here

comments powered by Disqus